Search Within

Vincent Miller

Formats
  1. Journal Article (152)
  2. Meeting Abstract (114)
  3. Book Section (2)
  4. Conference Paper (2)
Groups
  1. Department of Medicine (207)
  2. Solid Tumor Oncology Division (197)
  3. Thoracic Oncology (189)
  4. Department of Pathology and Laboratory Medicine (71)
  5. GSK Faculty (67)
  6. Human Oncology and Pathogenesis Program (64)

More Groups

People
  1. Mark Kris (172)
  2. Gregory Riely (79)
  3. William Pao (65)
  4. Marc Ladanyi (59)
  5. Christopher Azzoli (46)
  6. Maureen Zakowski (46)

More People

Years
  1. 2019 (1)
  2. 2017 (2)
  3. 2016 (1)
  4. 2015 (3)
  5. 2014 (5)
  6. 2013 (4)

More Years

Publications
  1. Journal of Clinical Oncology (80)
  2. Clinical Cancer Research (39)
  3. Journal of Thoracic Oncology (24)
  4. Seminars in Oncology (13)
  5. Cancer (10)
  6. Cancer Chemotherapy and Pharmacology (9)

More Publications

Publishers
  1. American Society of Clinical Oncology (80)
  2. American Association for Cancer Research (57)
  3. Elsevier Inc. (38)
  4. Elsevier Science, Inc. (11)
  5. Springer (10)
  6. Wiley Blackwell (10)

More Publishers

Results (270)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Gemcitabine toxicity
    Journal Article

    Vander Els, N.; Miller, V.
    Chest (1999)

    Fulltext@MSK | Save
  • Docetaxel (Taxotere) in combination with vinorelbine in non-small cell lung cancer
    Journal Article

    Miller, V.
    Seminars in Oncology (1999)

    Fulltext@MSK | Save
  • Oral cisapride for the control of delayed vomiting following high-dose cisplatin
    Journal Article

    Pizzo, B. A.; Pisters, K. M. W.; Miller, V. A.; Grant, S. C.; Baltzer, L.; Hinckley, L.; Kris, M. G.
    Supportive Care in Cancer (1999)

    Fulltext@MSK | Save
  • Phase II trials of vinorelbine and docetaxel in the treatment of advanced non-small cell lung cancer
    Journal Article

    Krug, L. M.; Miller, V. A.
    Seminars in Oncology (1999)

    Fulltext@MSK | Save
  • Strategies to eradicate minimal residual disease in small cell lung cancer: High-dose chemotherapy with autologous bone marrow transplantation, matrix metalloproteinase inhibitors, and BEC2 plus BCG vaccination
    Journal Article

    Krug, L. M.; Grant, S. C.; Miller, V. A.; Ng, K. K.; Kris, M. G.
    Seminars in Oncology (1999)

    Fulltext@MSK | Save
  • Immunogenicity of a fucosyl-GM1-keyhole limpet hemocyanin conjugate vaccine in patients with small cell lung cancer
    Journal Article

    Dickler, M. N.; Ragupathi, G.; Liu, N. X.; Musselli, C.; Martino, D. J.; Miller, V. A.; Kris, M. G.; Brezicka, F. T.; Livingston, P. O.; Grant, S. C.
    Clinical Cancer Research (1999)

    Fulltext@MSK | Save
  • Induction chemotherapy employing dose-intense cisplatin with mitomycin and vinblastine (MVP400), followed by thoracic surgery or irradiation, for patients with Stage III nonsmall cell lung carcinoma
    Journal Article

    Ng, K. K.; Kris, M. G.; Ginsberg, R. J.; Heelan, R. T.; Pisters, K. M. W.; Miller, V. A.; Grant, S. C.; Bains, M.; Rusch, V.; Rosenzweig, K. E.; more...
    Cancer (1999)

    Fulltext@MSK | Save
  • Phase I study of the sequential administration of edatrexate and paclitaxel in patients with advanced solid tumors
    Journal Article

    Rigas, J. R.; Kris, M. G.; Miller, V. A.; Pisters, K. M. W.; Heelan, R. T.; Grant, S. C.; Fennelly, D. W.; Chou, T. C.; Sirotnak, F. M.
    Annals of Oncology (1999)

    Fulltext@MSK | Save
  • New chemotherapeutic agents in NSCLC
    Book Section

    Miller, V. A.; Ng, K. K.; Grant, S. C.; Early, E.; Kris, M. G.
    In Roth, J. A.; Cox, J. D.; Hong, W. K. (Eds.) Lung Cancer. 2nd ed (1998)

    Fulltext@MSK | Save
  • Docetaxel in the management of advanced non-small cell lung cancer
    Journal Article

    Miller, V. A.
    Seminars in Oncology (1998)

    Fulltext@MSK | Save